Index | S&P 500 Capped 35/20 Health Care |
Investment focus | Equity, United States, Health Care |
Fund size | GBP 1,827 m |
Total expense ratio | 0.15% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 12.39% |
Inception/ Listing Date | 20 November 2015 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | iShares |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | State Street Fund Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Deloitte |
Fiscal Year End | 30 November |
Swiss representative | BlackRock Asset Management Schweiz AG |
Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
Securities lending | Yes |
Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
Eli Lilly & Co. | 13.43% |
UnitedHealth Group | 8.71% |
Johnson & Johnson | 6.54% |
Merck & Co., Inc. | 5.83% |
AbbVie, Inc. | 5.63% |
Thermo Fisher Scientific, Inc. | 3.92% |
Abbott Laboratories | 3.36% |
Amgen, Inc. | 3.12% |
Danaher Corp. | 3.06% |
Pfizer Inc. | 2.95% |
United States | 96.09% |
Ireland | 2.35% |
Other | 1.56% |
Health Care | 98.44% |
Other | 1.56% |
YTD | +10.41% |
1 month | +2.90% |
3 months | +3.24% |
6 months | +5.01% |
1 year | +12.01% |
3 years | +26.44% |
5 years | +66.91% |
Since inception (MAX) | +186.65% |
2023 | -3.80% |
2022 | +9.45% |
2021 | +27.24% |
2020 | +9.28% |
Volatility 1 year | 12.39% |
Volatility 3 years | 16.30% |
Volatility 5 years | 19.59% |
Return per risk 1 year | 0.97 |
Return per risk 3 years | 0.50 |
Return per risk 5 years | 0.55 |
Maximum drawdown 1 year | -5.62% |
Maximum drawdown 3 years | -15.33% |
Maximum drawdown 5 years | -19.63% |
Maximum drawdown since inception | -19.63% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
London Stock Exchange | GBX | IHCU | - - | - - | - |
gettex | EUR | QDVG | - - | - - | - |
Stuttgart Stock Exchange | EUR | QDVG | - - | - - | - |
Bolsa Mexicana de Valores | MXN | - | IUHCN MM | IUHCN.MX | |
London Stock Exchange | USD | IUHC | IUHC LN INAVIHCU | IHCU.L 3094INAV.DE | |
London Stock Exchange | GBP | - | IHCU LN INAVIHCG | IUHC.L 3092INAV.DE | |
SIX Swiss Exchange | USD | IUHC | IUHC SE INAVIHCU | IUHC.S 3094INAV.DE | |
XETRA | EUR | QDVG | QDVG GY INAVIHCE | QDVG.DE 309ZINAV.DE |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
Xtrackers MSCI USA Health Care UCITS ETF 1D | 578 | 0.12% p.a. | Distributing | Full replication |
iShares Nasdaq US Biotechnology UCITS ETF | 476 | 0.35% p.a. | Accumulating | Sampling |
SPDR S&P US Health Care Select Sector UCITS ETF | 360 | 0.15% p.a. | Accumulating | Full replication |
Invesco Nasdaq Biotech UCITS ETF | 307 | 0.40% p.a. | Accumulating | Swap-based |
Invesco US Health Care Sector UCITS ETF | 290 | 0.14% p.a. | Accumulating | Swap-based |